Factors that affect albumin concentration in dialysis patients and their relationship to vascular disease

Kidney International, Supplement

Volumn 63, Issue 84, 2003, Pages

  Kaysen, George A ^a   Don, Burl R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Acute phase; Albumin synthesis; Fibrinogen; Hemodialysis; Plasma volume

Indexed keywords

ALBUMIN; FIBRINOGEN; SERUM ALBUMIN;

ACUTE PHASE RESPONSE; ALBUMIN BLOOD LEVEL; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DIALYSIS; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPOALBUMINEMIA; INFLAMMATION; MAJOR CLINICAL STUDY; MORTALITY; PLASMA VOLUME; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RISK FACTOR; VASCULAR DISEASE; CHRONIC KIDNEY FAILURE; IMMUNOLOGY; METABOLISM; RENAL REPLACEMENT THERAPY; REVIEW; VASCULITIS;

ACUTE-PHASE REACTION; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; SERUM ALBUMIN; VASCULITIS;

EID: 0037408080     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.63.s84.20.x     Document Type: Conference Paper

References (42)

1. LOWRIE EG, LEW NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
2. YEUN JY, LEVINE RA, MANTADILOK V, KAYSEN GA: C-reactive protein predicts all cause and cardiovascular mortality in hemodialysis patients. Am. J. Kid Dis 35:469-476, 2000
3. KIRSCH R, FRITH L, BLACK E, HOFFENBERG R: Regulation of albumin synthesis and catabolism by alteration of dietary protein. Nature 217:578-579, 1968
4. ZUCCHELLI P, SANTORO A: Dry weight in hemodialysis: Volemic control. Semin Nephrol 1:286-290, 2001
5. PAIN VM, CLEMENS MJ, GARLICK PJ: The effect of dietary protein deficiency on albumin synthesis and on the concentration of active albumin messenger ribonucleic acid in rat liver. Biochem J 172:129-135, 1978
6. RIGAUD D, HASSID J, MEULEMANS A, et al: A paradoxical increase in resting energy expenditure in malnourished patients near death: The king penguin syndrome. Am J Clin Nutr 72:355-360, 2000
7. SMITH G, ROBINSON PH, FLECK A: Serum albumin distribution in early treated anorexia nervosa. Nutrition 12:677-684, 1996
8. BALLMER PE, MCNURLAN MA, GRANT I, GARLICK PJ: Down-regulation of albumin synthesis in the rat by human recombinant interleukin-1 or turpentine and the response to nutrients. J Parent Enteral Nutr 19:266-271, 1995
9. KAPLAN AA, HALLEY SE, LAPKIN RA, GRAEBER CW: Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int Feb 47:573-578, 1995
10. MOSHAGE HJ, JANSSEN JAM, FRANSSEN JH, et al: Study of the molecular mechanisms of decreased liver synthesis of albumin in inflammation. J Clin Invest 79:1635-1641, 1987
11. KAYSEN GA, RATHORE V, SHEARER GC, DEPNER TA: Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 48:510-516, 1995
12. KAYSEN GA, STEVENSON FT, DEPNER TA: Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 29:658-668, 1997
13. KAYSEN GA, CHERTOW GM, ADHIKARLA R, et al: Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int 60:333-340, 2001
14. BOLOGA RM, LEVINE DM, PARKER TS, et al: Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32:107-114, 1998
15. KAYSEN GA, DUBIN JA, Müller, et al: The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. Kidney Int 58:346-352, 2000
16. KAYSEN GA, DUBIN JA, MÜLLER HG, et al: Levels of alpha1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients. Kidney Int 60:2360-2366, 2001
17. KAYSEN GA, DUBIN JA, MÜLLER HG, et al: Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int 61:2240-2249, 2002
18. RIDKER PM, BURING JE, SHIH J, et al: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731-733, 1998
19. MATSUKI T, DULING BR: TNF-alpha modulates arteriolar reactivity secondary to a change in intimal permeability. Microcirculation 7:411-418, 2000
20. ZHANG C, REITER C, EISERICH JP, et al: L-arginine chlorination products inhibit endothelial nitric oxide production. J Biol Chem 276:27159-27165, 2001
21. MALIK I, DANESH J, WHINCUP P, et al: Soluble adhesion molecules and prediction of coronary heart disease: A prospective study and meta-analysis. Lancet 358:971-976, 2001
22. VAN LENTEN BJ, HAMA SY, DE BEER FC, et al: Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 96:2758-2767, 1995
23. SUZUKI K; KURIYAMA M; SAITO T; ICHINOSE A. Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5′-flanking region. J Clin Invest 15, 99:1361-1366, 1997
24. DIEPLINGER H, LACKNER C, KRONENBERG F, et al: Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest 91:397-401, 1993
25. KODA Y, NISHI S, SUZUKI M, HIRASAWA Y: Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients. Kidney Int (Suppl 71):S251-S253, 1999
26. LEDUE TB, NEVEUX LM, PALOMAKI GE, et al: The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase response. Clin Chim Acta 223:73-82, 1993
27. IRISH A: Cardiovascular disease, fibrinogen and the acute phase response: Associations with lipids and blood pressure in patients with chronic renal disease. Atherosclerosis 137:133-139, 1998
28. KOCH M, KUTKUHN B, TRENKWALDER E, et al: Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 8:1889-1898, 1997
29. SONG IS, YANG WS, KIM SB, et al: Association of plasma fibrinogen concentration with vascular access failure in hemodialysis patients. Nephrol Dial Transplant 14:137-141, 1999
30. YANO K, GROVE JS, CHEN R, et al: Plasma fibrinogen as a predictor of total and cause-specific mortality in elderly japanese-american men. Arterioscler Thromb Vasc Biol 21:1065-1070, 2001
31. JENSEN H, ROSSING N, ANDERSON SB, JARNUM S: Albumin metabolism in the nephrotic syndrome in adults. Clin Sci 33:445-457, 1967
32. KAYSEN GA, GAMBERTOGLIO. J, JIMINEZ I, et al: Effect of dietary protein intake on albumin homeostasis in nephrotic patients. Kidney Int 29:572-577 1986.
33. KAYSEN GA, SCHOENFELD PY: Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 25:107-114, 1984
34. SUN X, MARTIN V, WEISS RH, KAYSEN GA: Selective transcriptional augmentation of hepatic gene expression in the rat with Heymann nephritis. Am J Physiol 264:F441-F447, 1993
35. KANG J, HOLLAND M, JONES H, KAYSEN GA: Coordinate augmentation in expression of genes encoding transcription factors and liver secretory proteins in hypo-oncotic states. Kidney Int 56:452-460, 1999
36. DE SAIN-VAN DER VELDEN MG, KAYSEN GA, DE MEER K, et al: Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: Measurements with stable isotopes. Kidney Int 53:181-188, 1998
37. KAYSEN GA, SUN X, JONES H, JR, et al: Non-iron mediated alteration in hepatic transferrin gene expression in the nephrotic rat. Kidney Int 47:1068-1077, 1995
38. SUN X, JONES H JR, JOLES JA, et al: Apolipoprotein gene expression in analbuminemic rats and in rats with Heymann nephritis. Am J Physiol 262:F755-F761, 1992
39. KANG JJ, KAYSEN GA, JONES H, JR, HOLLAND MJ: Rat liver transcript profiling in normal and disease states using a kinetic polymerase chain reaction assay. Methods 13:437-443, 1997
40. GIORDANO M, DE FEO P, LUCIDI P, et al: Increased albumin and fibrinogen synthesis in hemodialysis patients with normal nutritional status. J Am Soc Nephrol 12:349-354, 2001
41. IMOBERDORF R, GARLICK PJ, MCNURLAN MA, et al: Enhanced synthesis of albumin and fibrinogen at high altitude. J Appl Physiol 90:528-537, 2001
42. KAYSEN GA, DUBIN JA, MÜLLER HG, et al: Impact of albumin synthesis rate and the acute phase response in the dual regulation of fibrinogen levels in hemodialysis patients. Kidney Int 63:315-322, 2003